Echo Health Ventures
VC Fund
Seattle, United States
Echo Health Ventures is a venture capital firm that focuses on investing in health care companies. From offices in Durham, Portland, and Seattle, Echo Health Ventures invests in health care companies. They work with portfolio companies to accelerate their innovations to scale nationally. As stage-agnostic investors, they are committed to a newapproach to strategic investing – an approach that brings more than capital to the table, an approach focused on developing deep, high-value relationships with their portfolio companies.
- Total investments:
- 62
- Last investment:
- Lead investor:
- 23%
Last updated:
For AI agents: llms.txt
Industries Echo Health Ventures invests in
Stages Echo Health Ventures invests in
Countries Echo Health Ventures invests in
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Dusty Lieb
|
|||
Karim Botros
|
|||
Kurt Sheline
|
|||
Rob Coppedge
|
|||
| See all 9 contacts → | |||
Investment Focus
Industry
- Health Care 30 (48%)
- Medical 12 (19%)
- mHealth 6 (10%)
- Hospital 6 (10%)
- Analytics 6 (10%)
Stage
- Series B 16 (26%)
- Series C 14 (23%)
- Series A 8 (13%)
- Series D 6 (10%)
- Funding Round 6 (10%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
Dusty Lieb
Partner
|
Partner | Total investments: 4 | Find email | |
|
Karim Botros
Managing Partner
|
Managing Partner | Total investments: 2 | Find email | |
|
Kurt Sheline
Partner
|
Partner | Total investments: 6 | Find email | |
|
Rob Coppedge
CEO & Founder
|
CEO & Founder | Total investments: 2 | Find email | |
Jessica Zeaske
Partner
|
Partner | Total investments: 8 | Find email | |
| See all 9 team members → | ||||
Investments
| Company | Description | Round | Links |
|---|---|---|---|
InStride Health
|
InStride Health provides evidence-based OCD and anxiety treatment to keep kids and teenagers engaged along the way. | $30M / Series C / Jun 15, 2026 | |
Optura
|
Optura is healthcare’s AI orchestration platform designed to turn disconnected pilots into a unified, enterprise-scale AI program. | $17.5M / Series A / May 14, 2026 | |
Lantern
|
Lantern is a specialty care platform connecting people with health plan members for surgeries and cancer treatment. | $30M / Venture - Series Unknown / Mar 19, 2026 | |
Codoxo
|
Codoxo uses AI technology to re-envision healthcare affordability and effectiveness. Its Forensic AI Platform uses a patented algorithm to identify problems and suspicious behavior earlier than traditional techniques which helps ensure our scarce healthcare dollars go to real patient care. It was founded in 2016 and is based in Atlanta, Georgia. | $35M / Series C / Dec 17, 2025 | |
Strive Health
|
Strive Health is a built-for-purpose company working with innovative payers and providers to transform kidney care. Strive Health significantly improves patient outcomes and experience with a high-touch, technology-enabled clinical model that cares for chronic kidney disease patients across their entire healthcare journey, from primary care-levelengagement through dialysis.Strive was launched out of Oxeon’s Venture Studio and is backed by New Enterprise Associates, Town Hall Ventures, Echo Health Ventures, and Ascension Ventures. | $300M / Series D / Sep 09, 2025 | |
Vori Health
|
Vori Health offers a new care delivery model for treating musculoskeletal conditions. Its nationwide, all-inclusive medical practice is evidence-based and uniquely positioned to address a multitude of back, neck, and other joint issues. The organization offers integrated medical and rehabilitation care, physical therapy, prescriptions, imaging andlab ordering, health coaching, nutritional guidance, community support and premium instructional content. Using a unique, virtual-first care model to help patients find the best path forward, Vori Health connects patients to a trained care team that includes a board-certified, non-operative physical medicine physician, a health coach navigator, and a physical therapist who collaboratively manage the initial patient assessment and coordinate all aspects of care. Learn more at www.vorihealth.com.The company was founded in 2020 and is headquartered in New York, NY. | $53M / Series B / Mar 11, 2025 | |
Thyme Care
|
Thyme Care is a healthcare company that provides oncology care management services. The company offers a patient- and provider-integrated oncology solution, partnering with health plans to facilitate whole-person care for their members. Thyme Care seeks to revolutionize cancer care by providing personalized and holistic support to patients. Thecompany envisions a future where every cancer patient can access high-quality, individualized care that meets their unique needs and circumstances. | $55M / Series C / Jul 16, 2024 | |
Heartbeat Health
|
Heartbeat Health is a healthcare technology company that delivers virtual-first cardiovascular disease prevention and management. Through its data-powered platform and clinical services, the company helps patients and at-risk organizations benefit from higher-value care by reducing cardiovascular risk and the likelihood of future adverse events. Itoffers tools and resources critical to supporting digital care by virtually connect patients with doctors securely and helps in sharing information in real-time, and collaborate on treatment and diet consultation, and helps patients to keep track of their heart health and be in touch with a cardiologist. | Jul 09, 2024 | |
|
Heartbeat Health
|
Heartbeat Health is a healthcare technology company that delivers virtual-first cardiovascular disease prevention and management. Through its data-powered platform and clinical services, the company helps patients and at-risk organizations benefit from higher-value care by reducing cardiovascular risk and the likelihood of future adverse events. Itoffers tools and resources critical to supporting digital care by virtually connect patients with doctors securely and helps in sharing information in real-time, and collaborate on treatment and diet consultation, and helps patients to keep track of their heart health and be in touch with a cardiologist. | $25M / Series C / Jul 09, 2024 | |
|
Thyme Care
|
Thyme Care is a healthcare company that provides oncology care management services. The company offers a patient- and provider-integrated oncology solution, partnering with health plans to facilitate whole-person care for their members. Thyme Care seeks to revolutionize cancer care by providing personalized and holistic support to patients. Thecompany envisions a future where every cancer patient can access high-quality, individualized care that meets their unique needs and circumstances. | Venture - Series Unknown / May 28, 2024 | |
| See all 62 investments → | |||
Co-Investors
Town Hall Ventures
11 deals together
.406 Ventures
10 deals together
Optum Ventures
9 deals together
LRVHealth
7 deals together
CVS Health Ventures
6 deals together
New Enterprise Associates
6 deals together
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Echo Health Ventures invest in?
Echo Health Ventures invests primarily in Health Care, Medical and mHealth startups, most often at Series B and Series C stage. Most of the 62 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Echo Health Ventures?
Public channels for Echo Health Ventures include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Echo Health Ventures?
The team at Echo Health Ventures includes Dusty Lieb (Partner), Karim Botros (Managing Partner) and Kurt Sheline (Partner), among 9 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
